OMAXENSEOmaxe Limited· RealtyHighNeutral
Announced Fri, 6 Feb, 2026 · 17:37 IST

Omaxe Q3 FY26 results: standalone revenue up 44% YoY, consolidated loss narrows

Emphasis Of MatterRevenue Growth 20pctRevenue DeclinePat NegativeResults View source PDFExplain this filing

OMAXE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.0%Reaction day
₹79.00
prior close
₹79.32
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+2.6%-2.6% vs market
Residential Commercial Projects peers, median of 61sector+1.8%-1.8% vs sector

On the reaction day the stock moved 2.6 pts less than Nifty Microcap 250 and 1.8 pts less than its Residential Commercial Projects peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.4
10m
-0.4
15m
-0.4
30m
-0.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.0+2.6-2.6+1.8-1.8
Next day
-1.3+3.6-4.9+2.2-3.4
2d
+0.0+3.1-3.1+2.0-2.0
3d
+1.3+2.6-1.3+0.3+0.9
4d
+0.0+1.1-1.1-1.1+1.1
5d
-0.3+0.3-0.6-1.9+1.6
1w
-0.1+1.6-1.7-1.4+1.3
15d
-0.6-3.9+3.3-6.7+6.1
1m
-7.8-8.1+0.3-12.0+4.2
2m
-3.7-3.1-0.6-8.0+4.4
3m
+9.2+9.2+0.1-0.8+10.0
UpDownMarket · Nifty Microcap 250Sector · Residential Commercial Projects peers, median of 61Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Omaxe Limited reported Q3 FY26 standalone revenue of Rs 109.18 cr, up about 44% YoY from Rs 76.03 cr. Standalone net loss narrowed to Rs 26.24 cr from Rs 40.30 cr. For 9M FY26, consolidated revenue fell about 11% to Rs 904.88 cr, but consolidated net loss narrowed to Rs 505.39 cr from Rs 536.73 cr. Standalone other equity is negative at about Rs 388 cr. Auditors flagged a SEBI order from July 2024 as emphasis of matter, with SAT hearing due March 24, 2026.

Likely market impact

Losses persist but are narrowing on standalone. Negative other equity and ongoing SEBI litigation remain key risks for shareholders.